Name
Purdue University Globle
NU576 NP II – Primary Care of Women’s Health
Prof. Name
Date
Contraception is an essential part of reproductive healthcare because it helps individuals prevent unintended pregnancies and plan when they want to have children. The most appropriate birth control method depends on a person’s pregnancy intentions, health history, lifestyle, and personal preferences. Healthcare providers should use patient-centered counseling and shared decision-making to help individuals choose a safe and effective option.
This guide covers contraceptive methods, their benefits and potential risks, counseling considerations, and strategies for preventing unintended pregnancy. It is designed to support nursing students studying reproductive health, contraception, and pregnancy prevention.
Contraception allows individuals and couples to make informed decisions about pregnancy timing and family planning. It supports reproductive autonomy and can help individuals achieve their educational, professional, and personal goals.
A patient-centered approach recognizes that every individual has different needs. Some patients may want short-term contraception, while others may prefer long-acting reversible contraception (LARC). Others may be planning a pregnancy soon and need guidance on stopping contraception and preparing for conception.
Effective contraceptive counseling should be respectful, confidential, and free from pressure. Healthcare professionals should help patients understand their options rather than directing them toward a particular method.
A comprehensive contraceptive consultation should begin by asking about the patient’s reproductive goals. Providers should determine whether the patient wants to become pregnant now, in the future, or not at all.
The consultation should also address medical history, current medications, previous contraceptive experiences, and concerns about side effects. Patients should receive clear information about effectiveness, administration, menstrual changes, and potential complications.
Important components include:
Pregnancy intentions and reproductive life planning.
Medical history and contraceptive risk factors.
Effectiveness of available birth control methods.
Side effects and expected menstrual changes.
Privacy, confidentiality, and access concerns.
Future fertility expectations.
STI prevention and screening.
Age-appropriate preventive healthcare.
Local laws affecting contraceptive access and prescribing.
Patients planning a future pregnancy should receive preconception counseling. This may include reviewing medications, managing chronic conditions, updating vaccinations, and taking a prenatal vitamin containing 400 micrograms of folic acid daily, unless a healthcare professional recommends a different dose.
There is no single contraceptive method that is ideal for everyone. The best choice is one that aligns with the patient’s health needs, pregnancy plans, preferences, and ability to use the method consistently.
Healthcare providers should explain how each method works and discuss both its advantages and limitations. Patients should also understand that contraceptive effectiveness varies depending on the method and how it is used.
Factors to consider include:
Administration: Pills, injections, implants, patches, vaginal rings, or intrauterine devices.
Frequency: Daily, weekly, monthly, every three months, or long-term use.
Effectiveness: Typical-use and perfect-use pregnancy prevention rates.
Menstrual effects: Possible changes in bleeding, cramping, or menstrual suppression.
Side effects: Potential adverse effects and individual tolerability.
Health benefits: Possible improvements in menstrual symptoms, acne, or other conditions.
Fertility: Expected return to fertility after discontinuation or removal.
Privacy: The patient’s comfort with visible or discreet methods.
The patient’s informed preference should guide contraceptive selection, provided the method is medically appropriate.
Combined hormonal contraceptives contain both estrogen and progestin. They prevent pregnancy primarily by suppressing ovulation and also produce changes in cervical mucus and the uterine lining.
Common forms include:
Combined oral contraceptive pills.
Transdermal contraceptive patches.
Combined hormonal vaginal rings.
These methods can be effective options for patients who prefer a reversible, hormone-based contraceptive. Their effectiveness depends on correct and consistent use.
In addition to pregnancy prevention, combined hormonal contraceptives may provide several non-contraceptive health benefits. Depending on the formulation, these methods may help reduce menstrual pain, regulate bleeding, and improve certain hormone-related symptoms.
Potential benefits include:
More predictable menstrual cycles.
Reduced menstrual cramps.
Decreased heavy menstrual bleeding.
Improvement in symptoms associated with endometriosis.
Reduced risk of endometrial and ovarian cancers.
Improvement in acne for some patients.
Reduction in symptoms of premenstrual syndrome in selected individuals.
Combined hormonal contraception may also reduce the risk of functional ovarian cysts and ectopic pregnancy, although it does not protect against sexually transmitted infections.
The estrogen dose and formulation can influence menstrual bleeding patterns. Many patients experience lighter or more predictable withdrawal bleeding when using combined hormonal contraceptives.
However, bleeding patterns vary. Some individuals experience spotting, particularly during the first few months of use. Healthcare providers should explain that irregular bleeding does not always indicate a serious problem, but persistent or concerning bleeding should be evaluated.
Before prescribing combined hormonal contraception, clinicians should review the patient’s medical history and assess for conditions that may increase the risk of cardiovascular or thromboembolic complications.
Important screening considerations include:
Migraine, especially migraine with aura.
Personal history of blood clots or thromboembolic disease.
Smoking status and age.
Hypertension and cardiovascular disease.
Liver disease.
Breast cancer history.
Postpartum status and breastfeeding.
Other medications and relevant risk factors.
Blood pressure measurement is important before initiating combined hormonal contraceptives. Providers should use the CDC’s U.S. Medical Eligibility Criteria for Contraceptive Use to determine whether a method is appropriate.
Combined hormonal contraception may be contraindicated in patients with certain conditions, including migraine with aura and certain high-risk thromboembolic conditions. Clinical eligibility must be assessed individually.
Progestin-only contraception contains no estrogen. These methods can be useful for individuals who cannot use estrogen-containing contraceptives or prefer an estrogen-free option.
Common progestin-only methods include:
Depot medroxyprogesterone acetate (DMPA) injections.
Etonogestrel contraceptive implants.
Progestin-only pills.
Levonorgestrel-releasing intrauterine devices.
Each method has different administration requirements, benefits, and side effects. Counseling should emphasize correct use and the expected changes in menstrual bleeding.
Depot medroxyprogesterone acetate, commonly known as Depo-Provera, is a progestin-only contraceptive injection administered approximately every 13 weeks, depending on the product and clinical guidance.
DMPA prevents pregnancy primarily by suppressing ovulation. It is a useful option for individuals who prefer not to take a daily pill.
Potential benefits include:
Reliable pregnancy prevention when injections are received on schedule.
Reduced menstrual bleeding over time.
Improvement in menstrual cramps.
Decreased risk of endometrial cancer.
Patients should also understand possible adverse effects. Weight gain and irregular bleeding can occur. Some users experience amenorrhea after continued use.
DMPA use is associated with a temporary reduction in bone mineral density in some individuals. Bone density often improves after discontinuation, although the degree and timing of recovery vary.
Providers should discuss individual risk factors, including bone health, age, and duration of use. Patients should maintain adequate calcium and vitamin D intake through diet or supplements when appropriate and engage in weight-bearing physical activity.
DMPA should not automatically be considered unsuitable for every patient because of bone health concerns. The benefits and risks should be assessed individually, using current prescribing guidance.
The etonogestrel implant, commonly known as Nexplanon, is a long-acting reversible contraceptive inserted under the skin of the upper arm.
The implant releases progestin and prevents pregnancy primarily by suppressing ovulation. It is one of the most effective reversible contraceptive methods available.
Key advantages include:
Greater than 99% effectiveness.
Long-term pregnancy prevention.
No need for daily contraceptive administration.
Rapid return to fertility after removal.
Suitability for many patients who cannot use estrogen.
The most common counseling concern is irregular bleeding. Patients may experience spotting, unpredictable bleeding, or amenorrhea. These changes do not necessarily mean the implant is ineffective.
Progestin-only pills are oral contraceptives that do not contain estrogen. They may be appropriate for breastfeeding individuals and patients with certain estrogen-related contraindications.
Patients should receive instructions on taking the pill consistently. The timing requirements vary by formulation, so providers should explain the specific product’s instructions.
Potential considerations include:
Daily administration.
Possible breakthrough bleeding.
Reduced contraceptive protection when pills are missed or taken outside the recommended schedule.
Need for additional contraception in certain missed-pill situations.
Progestin-only pills can be an effective estrogen-free alternative when used correctly.
Intrauterine devices are highly effective, long-acting reversible contraceptives placed inside the uterus by a trained healthcare professional. They are available in hormonal and non-hormonal forms.
IUDs are popular because they provide continuous pregnancy prevention without requiring daily or weekly action from the patient.
The copper IUD is a hormone-free contraceptive that releases copper ions, which interfere with sperm movement and fertilization.
Depending on the product, copper IUDs may provide contraception for several years, with some products approved for up to 10 or 12 years.
Potential benefits include:
Highly effective pregnancy prevention.
Long-term contraception.
No hormonal exposure.
Rapid return to fertility after removal.
Use as emergency contraception when inserted within the appropriate time frame.
Potential side effects include heavier menstrual bleeding and increased cramping, especially during the first several months after placement.
The copper IUD may not be the best choice for individuals who already experience heavy menstrual bleeding or significant dysmenorrhea.
Hormonal IUDs release levonorgestrel, a progestin that thickens cervical mucus and produces local changes in the uterine lining. Some formulations also suppress ovulation in a proportion of users.
Hormonal IUDs vary in duration, with products providing contraception for several years.
Common benefits include:
Greater than 99% effectiveness.
Long-term pregnancy prevention.
Reduced menstrual bleeding.
Reduced menstrual cramping for many users.
Possible amenorrhea over time.
Rapid return to fertility after removal.
Patients may experience spotting or irregular bleeding during the initial months. Over time, menstrual bleeding often becomes lighter, and some patients stop having periods.
Contraceptive counseling should reflect the patient’s age, medical history, reproductive goals, and personal circumstances. Certain populations require additional assessment to ensure safe and appropriate care.
Adolescents should receive confidential, respectful, and developmentally appropriate reproductive health counseling. Providers should explain available contraceptive methods without judgment and encourage questions about effectiveness, side effects, and STI prevention.
Long-acting reversible contraception may be appropriate for adolescents who want highly effective pregnancy prevention, but the decision should remain voluntary and patient-centered.
Healthcare professionals must also understand applicable state and local laws governing consent, confidentiality, and contraceptive access for minors.
Postpartum contraception supports birth spacing and helps patients plan future pregnancies. Counseling should begin during pregnancy when possible and continue after delivery.
Many contraceptive methods can be initiated immediately postpartum, depending on the method, breastfeeding status, and individual medical considerations.
For example, estrogen-containing contraceptives are generally not appropriate immediately after delivery because of increased venous thromboembolism risk. Progestin-only methods and certain IUDs may be suitable earlier.
Providers should assess:
Breastfeeding status.
Postpartum timing.
Risk of blood clots.
Patient’s preferred pregnancy spacing.
Medical eligibility for the selected method.
Patients who want to prevent pregnancy after an abortion can often begin contraception immediately. Starting contraception at the time of abortion care can help reduce the risk of another unintended pregnancy.
The appropriate method depends on the patient’s preference, medical condition, and the type of abortion care received. IUD placement may be possible immediately after certain abortion procedures when clinically appropriate.
Individuals with chronic medical conditions require individualized contraceptive recommendations. Providers should review current medications, disease severity, and potential contraindications.
Conditions that may influence contraceptive selection include:
Obesity.
Cardiovascular disease.
Hypertension.
Diabetes.
Liver disease.
Cancer history.
Substance use disorders.
Intellectual or developmental disabilities.
The CDC’s Medical Eligibility Criteria provides guidance for selecting contraceptive methods based on specific medical conditions.
A contraceptive visit is an opportunity to address broader preventive healthcare needs. Providers should not focus only on pregnancy prevention but should also consider sexual health, reproductive planning, and routine healthcare.
Preventive counseling may include:
STI screening based on age, sexual history, and risk factors.
Condom use and safer sex practices.
Pregnancy planning and preconception counseling.
Immunization review.
Cervical cancer screening when indicated.
Blood pressure assessment.
Evaluation of medication use.
Discussion of reproductive goals.
Most contraceptive methods do not protect against STIs. Patients who need STI protection should be counseled about condoms and other barrier methods.
The most suitable contraceptive method depends on what the patient wants to achieve. A patient seeking long-term pregnancy prevention may prefer an IUD or implant, while someone who wants more control over starting or stopping contraception may choose pills, a patch, or a vaginal ring.
Patients may also prioritize specific non-contraceptive benefits.
Some combined oral contraceptives may improve acne by reducing androgen-related effects. Formulations containing ethinyl estradiol and drospirenone, such as Yaz, may be prescribed for selected patients.
However, these medications are not appropriate for everyone. Providers must assess contraindications, including migraine with aura, thromboembolic risk, and cardiovascular conditions, before prescribing estrogen-containing contraception.
Hormonal IUDs and combined hormonal contraceptives can reduce menstrual bleeding for many patients. Hormonal IUDs are particularly useful for individuals seeking long-term contraception with the possibility of lighter periods or amenorrhea.
The copper IUD may have the opposite effect and increase menstrual bleeding, especially early after insertion.
Individuals who want highly effective contraception without daily administration may prefer LARC methods.
These include:
Etonogestrel implants.
Hormonal IUDs.
Copper IUDs.
These methods offer long-term pregnancy prevention and do not require frequent action from the patient.
Patients who want to become pregnant soon may prefer short-acting methods that can be discontinued easily. Most contraceptive methods allow a return to fertility after discontinuation or removal, although the timing varies.
DMPA injections may delay the return to ovulation and fertility longer than other reversible methods. This should be discussed with patients who plan pregnancy in the near future.
Shared decision-making is the foundation of effective contraceptive counseling. It allows healthcare providers to combine clinical knowledge with the patient’s values, preferences, and reproductive goals.
A successful counseling visit should help patients understand:
How the selected method prevents pregnancy.
How effective it is with typical and correct use.
How often it must be used or replaced.
Potential side effects and complications.
Whether it protects against STIs.
What to do if a dose is missed or a device is expelled.
How and when fertility is expected to return.
Providers should also explain alternative options so patients can make informed decisions without feeling pressured.
Contraception is an important component of reproductive health and unintended pregnancy prevention. Combined hormonal contraceptives, progestin-only methods, implants, and IUDs offer different advantages and limitations.
The most appropriate method depends on the patient’s medical eligibility, reproductive goals, lifestyle, and personal preferences. Nurses and other healthcare professionals play a critical role in providing accurate education, assessing risk factors, and supporting informed decision-making.
By incorporating contraceptive counseling into routine preventive care, healthcare providers can help patients achieve their reproductive goals and improve overall health outcomes.
Long-acting reversible contraceptives, including contraceptive implants and IUDs, are among the most effective reversible birth control methods. They provide greater than 99% effectiveness with typical use because they do not require daily adherence.
Combined hormonal contraceptives contain estrogen and progestin, while progestin-only methods contain no estrogen. Progestin-only contraception may be suitable for individuals who cannot use estrogen-containing methods.
Most contraceptive methods do not protect against STIs. Condoms can reduce the risk of many sexually transmitted infections when used correctly and consistently.
Most reversible contraceptive methods do not cause permanent infertility. Fertility generally returns after discontinuation or removal, although DMPA injections may delay the return of ovulation.
Hormonal IUDs and some combined hormonal contraceptives can help reduce heavy menstrual bleeding. The copper IUD may increase menstrual bleeding and may not be the preferred option for patients with heavy periods.
The provider should review medical history, blood pressure, migraine history, smoking status, cardiovascular risk, thromboembolic history, and other contraindications. The CDC Medical Eligibility Criteria should be used to guide safe prescribing.
American College of Obstetricians and Gynecologists. (n.d.). Long-acting reversible contraception (LARC): Intrauterine device and implant. https://www.acog.org/womens-health
Centers for Disease Control and Prevention. (2024). U.S. medical eligibility criteria for contraceptive use, 2024. https://www.cdc.gov/contraception/hcp/usmec/
Centers for Disease Control and Prevention. (2024). U.S. selected practice recommendations for contraceptive use, 2024. https://www.cdc.gov/contraception/hcp/usspr/
Trussell, J. (2011). Contraceptive failure in the United States. Contraception, 83(5), 397–404. https://doi.org/10.1016/j.contraception.2011.01.021
World Health Organization. (2023). Family planning/contraception methods. https://www.who.int/news-room/fact-sheets/detail/family-planning-contraception
